Columbia Research Enhanced Value ETF (REVS)

NYSEARCA: REVS · Real-Time Price · USD
29.86
-0.05 (-0.17%)
Feb 27, 2026, 4:00 PM EST - Market closed
-0.17%
Assets $221.13M
Expense Ratio 0.19%
PE Ratio 18.17
Shares Out 7.35M
Dividend (ttm) $0.60
Dividend Yield 2.02%
Ex-Dividend Date Dec 18, 2025
Payout Ratio 36.81%
1-Year Return +16.04%
Volume 9,671
Open 29.75
Previous Close 29.91
Day's Range 29.62 - 29.86
52-Week Low 21.79
52-Week High 30.17
Beta 0.82
Holdings 314
Inception Date Sep 25, 2019

About REVS

Fund Home Page

The Columbia Research Enhanced Value ETF (REVS) is an exchange-traded fund that mostly invests in large cap equity. The fund tracks an index of US stocks pulled from the Russell 1000 Value Index. REVS index uses multifactor selection and market cap weighting. REVS was launched on Sep 25, 2019 and is issued by Columbia Threadneedle.

Asset Class Equity
Category Large Value
Region North America
Stock Exchange NYSEARCA
Ticker Symbol REVS
Index Tracked Beta Advantage Research Enhanced US Value Index

Top 10 Holdings

26.49% of assets
Name Symbol Weight
The Procter & Gamble Company PG 3.75%
Wells Fargo & Company WFC 3.55%
Exxon Mobil Corporation XOM 3.42%
Alphabet Inc. GOOGL 2.66%
Cisco Systems, Inc. CSCO 2.63%
Pfizer Inc. PFE 2.30%
Citigroup Inc. C 2.19%
Alphabet Inc. GOOG 2.16%
The Charles Schwab Corporation SCHW 1.95%
Chevron Corporation CVX 1.88%
View More Holdings

Dividends

Ex-Dividend Amount Pay Date
Dec 18, 2025 $0.60215 Dec 26, 2025
Dec 18, 2024 $0.46667 Dec 26, 2024
Dec 18, 2023 $0.53855 Dec 26, 2023
Dec 19, 2022 $0.48105 Dec 27, 2022
Dec 20, 2021 $0.25246 Dec 27, 2021
Dec 18, 2020 $4.66911 Dec 28, 2020
Full Dividend History

News

Growth Stocks Signaling Value Cycles

Since September 2020, value stocks finally have rallied as the Russell 1000 Value Index has outperformed the Russell 1000 Growth by almost 21%. When spreads narrowed from their highs, the value cycle ...

5 years ago - Seeking Alpha